FdaApplication
ANDA 219918
Identifiers
- fda_app_no: ANDA219918
Properties
| Property | Value |
|---|---|
| applicant_name | NOVITIUM PHARMA LLC |
| application_type | ANDA |
| approval_date | 2026-06-29 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIFAMPIN | RIFAMPIN | 150MG | CAPSULE;ORAL |
| RIFAMPIN | RIFAMPIN | 300MG | CAPSULE;ORAL |
2 products